CaliPharms, Inc.
KGET
Rank in Stocks
#33511
CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis... CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States. The company's primary focus lies within the THC and CBD-infused beverage sector. It rebranded to CaliPharms, Inc. in January 2017, having previously operated under the name Kleangas Energy Technologies, Inc. The corporate headquarters for CaliPharms, Inc. are located in Temecula, California.
Share Price
$0.00004
Last synced: 2026-11-06
Market Cap
$474.35K
Change (1 day)
0.00%
Change (1 year)
3,900.00%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade CaliPharms, Inc. (KGET)
Category
Healthcare
EPS for CaliPharms, Inc. (KGET)
EPS as of September 2014 TTM: $0.00
According to CaliPharms, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2017 the company had an EPS of 0.00, equal to its 2016 EPS of 0.00.
EPS history for CaliPharms, Inc. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | -50.00% |
| 2015 | 0.00 | 100.00% |
| 2013 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -433,526.67% |
DE
|
|
| $6.08 | -405,273.33% |
DE
|
|
| $1.55 | -103,473.33% |
JP
|
|
| $3.66 | -244,100.00% |
CH
|
|
| $0.45 | -30,100.00% |
IL
|
Questions about CaliPharms, Inc.'s earnings per share (EPS)
What is CaliPharms, Inc.'s earnings per share (EPS)?
CaliPharms, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2014.
What was CaliPharms, Inc.'s earnings per share (EPS) in 2017?
In 2017, CaliPharms, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2016.
How has CaliPharms, Inc.'s earnings per share (EPS) changed since 2013?
From 2013 to 2017, CaliPharms, Inc.'s earnings per share (EPS) was highest in 2017 (0.00) and lowest in 2017 (0.00).
How does CaliPharms, Inc.'s earnings per share (EPS) compare with similar companies?
CaliPharms, Inc.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.